VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 53 filers reported holding VERASTEM INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $17,349 | -9.8% | 41,806 | -13.1% | 0.00% | – |
Q4 2022 | $19,234 | -58.2% | 48,085 | -11.5% | 0.00% | – |
Q3 2022 | $46,000 | -35.2% | 54,364 | -11.1% | 0.00% | – |
Q2 2022 | $71,000 | -27.6% | 61,166 | -12.3% | 0.00% | – |
Q1 2022 | $98,000 | -91.3% | 69,776 | -87.3% | 0.00% | – |
Q4 2021 | $1,123,000 | -27.6% | 547,929 | +8.7% | 0.00% | – |
Q3 2021 | $1,552,000 | +305.2% | 503,917 | +435.0% | 0.00% | – |
Q2 2021 | $383,000 | +49.0% | 94,191 | -9.5% | 0.00% | – |
Q1 2021 | $257,000 | +17.4% | 104,030 | +1.3% | 0.00% | – |
Q4 2020 | $219,000 | +95.5% | 102,665 | +10.7% | 0.00% | – |
Q3 2020 | $112,000 | -59.9% | 92,701 | -42.9% | 0.00% | – |
Q2 2020 | $279,000 | +7.7% | 162,289 | +65.7% | 0.00% | – |
Q1 2020 | $259,000 | +55.1% | 97,950 | -21.3% | 0.00% | – |
Q4 2019 | $167,000 | +4.4% | 124,458 | -5.6% | 0.00% | – |
Q3 2019 | $160,000 | -27.6% | 131,831 | -10.2% | 0.00% | – |
Q2 2019 | $221,000 | -56.7% | 146,755 | -15.0% | 0.00% | – |
Q1 2019 | $510,000 | -87.6% | 172,598 | -85.9% | 0.00% | -100.0% |
Q4 2018 | $4,104,000 | +129.1% | 1,221,494 | +394.6% | 0.00% | +100.0% |
Q3 2018 | $1,791,000 | +54.4% | 246,986 | +46.4% | 0.00% | 0.0% |
Q2 2018 | $1,160,000 | +146.3% | 168,663 | +6.7% | 0.00% | – |
Q1 2018 | $471,000 | -14.8% | 158,022 | -12.2% | 0.00% | – |
Q4 2017 | $553,000 | -52.0% | 180,030 | -26.5% | 0.00% | -100.0% |
Q3 2017 | $1,151,000 | +193.6% | 244,884 | +36.3% | 0.00% | – |
Q2 2017 | $392,000 | +60.7% | 179,607 | +52.5% | 0.00% | – |
Q1 2017 | $244,000 | +53.5% | 117,771 | -16.8% | 0.00% | – |
Q4 2016 | $159,000 | +17.8% | 141,628 | +39.8% | 0.00% | – |
Q3 2016 | $135,000 | -15.1% | 101,330 | -17.3% | 0.00% | – |
Q2 2016 | $159,000 | -34.0% | 122,556 | -19.7% | 0.00% | – |
Q1 2016 | $241,000 | -33.6% | 152,690 | -21.8% | 0.00% | – |
Q4 2015 | $363,000 | -51.0% | 195,375 | -52.8% | 0.00% | -100.0% |
Q3 2015 | $741,000 | -88.5% | 413,687 | -51.6% | 0.00% | -75.0% |
Q2 2015 | $6,450,000 | -24.9% | 855,499 | +1.4% | 0.00% | -33.3% |
Q1 2015 | $8,583,000 | +43.3% | 844,005 | +28.8% | 0.01% | +50.0% |
Q4 2014 | $5,991,000 | – | 655,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 2,951,000 | $4,161,000 | 1.39% |
MPM BioImpact LLC | 3,244,650 | $4,575,000 | 1.23% |
BVF INC/IL | 19,974,658 | $28,164,000 | 1.13% |
Opaleye Management Inc. | 2,325,000 | $3,278,000 | 1.02% |
ACUTA CAPITAL PARTNERS, LLC | 996,951 | $1,406,000 | 0.66% |
Telemetry Investments, L.L.C. | 135,000 | $190,000 | 0.30% |
Soleus Capital Management, L.P. | 1,644,500 | $2,319,000 | 0.30% |
Baker Brothers Advisors | 26,988,898 | $38,054,000 | 0.22% |
Ikarian Capital, LLC | 678,023 | $956,000 | 0.13% |
Samalin Investment Counsel, LLC | 124,000 | $175,000 | 0.11% |